CHARACTERISTICS OF PATIENTS STAYING IN A SPECIALIZED UNIT FOR TUBERCULOSIS PATIENTS WITH CONCURRENT HIV INFECTION
https://doi.org/10.21292/2075-1230-2018-96-8-37-41
Abstract
The objective of the study: to analyze clinical data of patients staying in a specialized unit for tuberculosis patients with concurrent HIV infection.
Subjects and methods. The case histories of all patients staying in the unit for TB/HIV co-infection of Surgut Clinical TB Dispensary discharged in 2016 were retrospectively analyzed, totally there were 231 such patients.
Results. Tuberculous lesions in the HIV infected patients were more disseminated (pulmonary disseminated tuberculosis was in 51.1% of patients and generalized forms with lesions in the lungs and other organs were in 17.9% of patients additionally). Cavities were diagnosed in 45.5% of pulmonary tuberculosis patients, and bacillary excretion was detected in 60.4% (among HIVnegative patients, registered in the city, those rates made 38.3 and 42.3% respectively). The rate of multiple drug resistance made 9.9% in all pulmonary tuberculosis patients or 44% among the patients with drug resistance, and extensive drug resistance made 1.4 and 6.1% respectively.
Along with anti-tuberculosis chemotherapy, 45.9% of patients received antiretroviral therapy, and 10.0% of them rejected it.
Only 36.7% of patients completed the intensive phase of treatment, 29.7% defaulted from treatment and left hospital at their will, 17.5% died, and the remaining patients were transferred to some other medical units (for surgery or to manage some concurrent condition) or they were discharged from the hospital due to violations of the discipline.
While on treatment, 57.5% of the patients with bacillary excretion had their sputum converted (by culture).
About the Author
N. V. Kuzmina
Surgut State University.
Russian Federation
Russian Federation
Natalya V. Kuzmina , Professor of Department for Multiple Discipline Clinical Training.
Surgut.
References
1. Vasilyeva I.A., Belilovsky E.M., Borisov S.E., Sterlikov S.А. Global tuberculosis reports by WHO, compilation and interpretation. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 5, pp. 7-16. (In Russ.)
2. Kasaeva T.Ch., Gabbasova L.А., Vasilyeva I.А., Moskalev А.А. et al. Tuberkulez v Rossiyskoy Federatsii 2012, 2013, 2014 g. Аnaliticheskiy obzor statisticheskikh pokazateley, ispolzuemykh v Rossiyskoy Federatsii i v mire. [Tuberculosis in the Russian Federation in 2011, 2013. 2014. Analytic review of statistic rates used in the Russian Federation and in the world]. Moscow, 2015, 312 p.
3. Koretskaya N.M., Narkevich А.N. Detection and characteristics of respiratory tuberculosis in HIV infection. Аkadem. Journal Zapadnoy Sibiri, 2013, vol. 9, no. 1 (44), pp. 52-53. (In Russ.)
4. Koretskaya N.M., Bolshakova I.А. Typical features of primary drug resistance and viability of mycobacteria in tuberculosis patients with concurrent HIV-infection. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 2, pp. 16-20. (In Russ.)
5. Mordyk А.V., Ivanova O.G., Sitnikova S.V. Tuberculosis with concurrent HIV-infection: causes of treatment failures. Omskiy Nauchny Vestnik, 2015, no. 144, pp. 23-26. (In Russ.)
6. Nechaeva O.B. Tuberculosis situation among HIV positive people in the Russian Federation. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 3, pp. 13-19. (In Russ.)
7. Пантелеев А.М. Bacillary excretion and drug resistance in case of tuberculosis in HIV patients in St.Petersburg. VICH-Infektsiya i Immunosuprssiya, 2011, no. 2, pp. 57-62. (In Russ.)
8. Sterlikov S.А., Testov V.V., Vasilyeva I.А. Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and worldwide. Tuberculosis and Lung Diseases, 2016, vol. 94, no. 1, pp. 22-27. (In Russ.)
9. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniyu tuberkuleza u bolnykh VICH-infektsiey. [Federal clinical recommendations on diagnostics and treatment of tuberculous in HIV patients]. Moscow, 2016, 41 p.
10. Tsybikova E.B., Zubova N.А. Tuberculosis preventive chemotherapy in the HIV infected in the regions of the Russian Federation with a high prevalence of HIV infection. Tuberculosis and Lung Diseases, 2016, vol. 94, no. 2, pp. 16-24. (In Russ.)
11. Pym A.S., Diacon A.H., Tang S.J., Conradie F., Danilovits M., Chuchottaworn C., Vasilyeva I. et al. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur. Respir. J., 2016, vol. 47, no. 2, pp. 564-574.
Review
For citations:
Kuzmina N.V. CHARACTERISTICS OF PATIENTS STAYING IN A SPECIALIZED UNIT FOR TUBERCULOSIS PATIENTS WITH CONCURRENT HIV INFECTION. Tuberculosis and Lung Diseases. 2018;96(8):37-41. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-8-37-41
Views:
816
Email this article 